The world’s first human clinical trials for a treatment against Hendra virus, a rare but deadly viral disease, have just begun in Australia, using a human monoclonal antibody.
The world’s first human clinical trials for a treatment against Hendra virus, a rare but deadly viral disease, have just begun in Australia, using a human monoclonal antibody.